CLINICAL_TRIALS
trial_result
· 2010-06-22
Clinical Trial Update: Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA) [Phase 2]
Summary
Phase 2 trial evaluating dutasteride for spinal and bulbar muscular atrophy (Kennedy's disease) has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Kennedy's Disease, Spinal and Bulbar Muscular Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2010-06-22